Medtronic Endovascular
Clinical trials sponsored by Medtronic Endovascular, explained in plain language.
-
New gel stops dangerous bleeding without surgery in early trial
Disease control Recruiting nowThis study tests a special gel called Onyx™ LES to stop active bleeding in arteries outside the brain and heart. About 119 adults with severe bleeding from trauma, ulcers, or other causes will receive the gel during a procedure. The goal is to see if it safely stops bleeding with…
Phase: NA • Sponsor: Medtronic Endovascular • Aim: Disease control
Last updated May 26, 2026 04:51 UTC
-
Doctors test new Clot-Busting device in first human use
Knowledge-focused Recruiting nowThis study surveys doctors who use the Liberant system to remove fresh blood clots from leg arteries and veins. About 50 patients aged 22 or older will be treated. The goal is to confirm the device is safe and works as intended.
Sponsor: Medtronic Endovascular • Aim: Knowledge-focused
Last updated May 26, 2026 04:46 UTC